IconOVir

0 followers


IconOVir Bio is a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer.

Industries

Employees

11-50

Links


Org chart

Mark McCamish
President & CEO
Collapse
John Huynh
Chief Technology Officer
Christopher Wilfong
Corporate Development & Strategy Advisor
Sean Algeo
Controller & Treasurer
Nicole Van De Leuv
Head of Legal
Dustin Wright
Vice President, Clinical Operations

Board & advisors

David Chang
Board Chair
Joshua Kazam
Board Member
Arie Belldegrun
Board Member
Helen Kim
Board Member
Jakob Loven
Board Member
Clodagh O’Shea
Scientific Advisory Board Chair
William Kaelin
Scientific Advisor
Owen Witte
Scientific Advisor
Frank McCormick
Scientific Advisor
Mark Chao
Scientific Advisor